Merial Overview

  • Founded

  • 1997

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 6,900

Employees
  • Latest Deal Type

  • M&A

  • Financing Rounds

  • 3

  • Investments

  • 7

Merial General Information

Description

Manufacturer of animal medicines. The company deals with animal health, vaccines, veterinary medicines and other pharmaceuticals.

Contact Information

Website
www.merial.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors/Wholesale
Other Industries
Pharmaceuticals
Acquirer
Boehringer Ingelheim
Primary Office
  • 29, Avenue Tony Garnier
  • 69007 Lyon
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Merial Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Merial‘s full profile, request access.

Request a free trial

Merial Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Manufacturer of animal medicines. The company deals with animal health, vaccines, veterinary medicines and other pharmac
Distributors/Wholesale
Lyon, France
6,900 As of 2017
000000&0

0000 0

re et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi u
00000 0000000000 00000000
Libourne, France
0000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Merial Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
0000 00000 0000000 Private Equity-Backed Libourne, France 0000 00000 000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Merial Patents

  • 595

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 19

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Merial Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140271708-A1 Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g Abandoned 15-Mar-2013 0000000000
US-20130177591-A1 Lipid based adjuvants for dna plasmids Abandoned 10-Jan-2012 000000000
US-20130079394-A1 Indirect modeling of new repellent molecules active against insects, acarids, and other arthropods Abandoned 23-Sep-2011 0000000000 0
CA-2784141-A1 Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles Granted 17-Dec-2009 0000000000
CA-2784141-C Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles Active 17-Dec-2009 C07D471/04
To view Merial’s complete patent history, request access »

Merial Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Merial Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Merial‘s full profile, request access.

Request a free trial

Merial Investments & Acquisitions (7)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 02-Mar-2015 000000000 Buildings and Property 0000000 0
00000 (000000 12-Feb-2015 0000000000 Pharmaceuticals 0000000 0
00000 0000000 31-Jan-2013 0000000000 Other Pharmaceuticals and Biotechnology 000é 0000
0000000 00000 02-Apr-2012 0000000000 Pharmaceuticals
Scynexis 27-Mar-2008 Later Stage VC 000.00 Drug Discovery
You’re viewing 5 of 7 investments and acquisitions. Get the full list »

Merial Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 02-Apr-2012 000000000000000000 Completed
  • 000000
Scynexis 27-Mar-2008 Later Stage VC 000.00 Completed
  • 7 buyers
To view Merial’s complete exits history, request access »